Mathias Vormehr

11PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NanomedicineMedical molecular engineering of nucleic acids and proteinsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 04, 2026
Messenger RNA delivery of a dual CD25/CD122 affinity-tuned IL-2 variant prolongs exposure and potentiates antitumor T cell immunity.

|Jun 17, 2024
RNA-encoded Interleukin 2 with Extended Bioavailability Amplifies RNA Vaccine-Induced Antitumor T-cell Immunity.

Daniel Peters, Lena M Kranz, David Eisel

|May 27, 2021
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

Ugur Sahin, Alexander Muik, Isabel Vogler

|Apr 16, 2021
mRNA therapeutics in cancer immunotherapy.

Jan D Beck, Daniel Reidenbach, Nadja Salomon

|Feb 01, 2021
BNT162b vaccines protect rhesus macaques from SARS-CoV-2.

Annette B Vogel, Isis Kanevsky, Ye Che

|Sep 30, 2020
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.

Ugur Sahin, Alexander Muik, Evelyna Derhovanessian

Pageof 2

Frequent Collaborators

8 joint publications

Ugur Sahin

8 joint publications

Lena M Kranz

6 joint publications

Alexander Muik

5 joint publications

Pei-Yong Shi